Free Trial

Dyne Therapeutics (DYN) SEC Filings & 10K Form

Dyne Therapeutics logo
$11.45 -0.35 (-2.97%)
Closing price 03/28/2025 04:00 PM Eastern
Extended Trading
$11.66 +0.21 (+1.79%)
As of 03/28/2025 07:08 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Recent Dyne Therapeutics SEC Filings

DateFilerForm TypeView
03/27/2025
6:31 AM
Dyne Therapeutics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
03/20/2025
3:08 PM
Dyne Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/05/2025
3:07 PM
Dyne Therapeutics (Subject)
Scalzo Richard William (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/05/2025
3:08 PM
Beskrovnaya Oxana (Reporting)
Dyne Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/05/2025
3:09 PM
Cox John (Reporting)
Dyne Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/05/2025
3:10 PM
Dyne Therapeutics (Subject)
Kerr Douglas (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/27/2025
6:25 AM
Dyne Therapeutics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
02/27/2025
6:35 AM
Dyne Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/27/2025
6:20 AM
Dyne Therapeutics (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/14/2025
11:22 AM
Dyne Therapeutics (Subject)
JANUS HENDERSON GROUP PLC (Filed by)
Form SCHEDULE 13G/A
02/14/2025
8:00 AM
Dyne Therapeutics (Subject)
RTW INVESTMENTS, LP (Filed by)
Form SCHEDULE 13G/A
02/12/2025
8:28 AM
Dyne Therapeutics (Subject)
FMR LLC (Filed by)
Form SCHEDULE 13G/A
02/03/2025
4:07 PM
Dyne Therapeutics (Subject)
Point72 Asset Management, L.P. (Filed by)
Form SCHEDULE 13G
01/29/2025
3:15 PM
Dyne Therapeutics (Issuer)
Rhodes Jason P (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/10/2025
5:56 AM
Dyne Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/11/2024
7:40 PM
Dyne Therapeutics (Issuer)
Scalzo Richard William (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/11/2024
7:41 PM
Beskrovnaya Oxana (Reporting)
Dyne Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/11/2024
3:18 PM
Dyne Therapeutics (Subject)
Scalzo Richard William (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/11/2024
3:19 PM
Beskrovnaya Oxana (Reporting)
Dyne Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/11/2024
3:20 PM
Dyne Therapeutics (Subject)
HIGH SUSANNA GATTI (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/22/2024
3:06 PM
Dyne Therapeutics (Subject)
Forbion Capital Fund IV Cooperatief U.A. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/18/2024
6:42 PM
Dyne Therapeutics (Issuer)
Incerti Carlo (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/18/2024
4:31 PM
Dyne Therapeutics (Issuer)
Rhodes Jason P (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/18/2024
3:40 PM
Dyne Therapeutics (Subject)
Incerti Carlo (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/14/2024
4:46 PM
Dyne Therapeutics (Subject)
RA CAPITAL MANAGEMENT, L.P. (Filed by)
Form SC 13G/A
11/14/2024
3:32 PM
Atlas Venture Fund XI, L.P. (Filed by)
Dyne Therapeutics (Subject)
Form SC 13G/A
11/14/2024
9:28 AM
Dyne Therapeutics (Subject)
JANUS HENDERSON GROUP PLC (Filed by)
Form SC 13G
11/14/2024
8:27 AM
Deep Track Capital, LP (Filed by)
Dyne Therapeutics (Subject)
Form SC 13G/A
11/14/2024
6:00 AM
Dyne Therapeutics (Subject)
Forbion Capital Fund IV Cooperatief U.A. (Filed by)
Form SC 13G/A
11/14/2024
5:34 AM
Dyne Therapeutics (Subject)
RTW INVESTMENTS, LP (Filed by)
Form SC 13G
11/12/2024
8:55 AM
Dyne Therapeutics (Subject)
FMR LLC (Filed by)
Form SC 13G
11/08/2024
4:31 PM
BlackRock, Inc. (Filed by)
Dyne Therapeutics (Subject)
Form SC 13G/A
11/04/2024
9:20 AM
Dyne Therapeutics (Subject)
VANGUARD GROUP INC (Filed by)
Form SC 13G/A
10/22/2024
3:05 PM
Dyne Therapeutics (Issuer)
Kersten Dirk (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/22/2024
2:24 PM
BlackRock, Inc. (Filed by)
Dyne Therapeutics (Subject)
Form SC 13G/A
10/03/2024
3:05 PM
Dyne Therapeutics (Issuer)
Kersten Dirk (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/27/2024
3:05 PM
Dyne Therapeutics (Issuer)
Kersten Dirk (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/24/2024
3:05 PM
Dyne Therapeutics (Issuer)
Kersten Dirk (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/19/2024
3:51 PM
Beskrovnaya Oxana (Reporting)
Dyne Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/19/2024
3:52 PM
Dyne Therapeutics (Issuer)
Scalzo Richard William (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/19/2024
3:52 PM
Dyne Therapeutics (Issuer)
HIGH SUSANNA GATTI (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
Trump’s Great Society (Ad)

Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to move your money now.

Millions of Americans are about to be wiped out, while others could make a fortune… click here to ma
09/18/2024
3:20 PM
Dyne Therapeutics (Subject)
HIGH SUSANNA GATTI (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/18/2024
3:21 PM
Dyne Therapeutics (Subject)
McNeill Jonathan (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/18/2024
3:23 PM
Beskrovnaya Oxana (Reporting)
Dyne Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/18/2024
3:24 PM
Dyne Therapeutics (Subject)
Scalzo Richard William (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/18/2024
3:05 PM
Dyne Therapeutics (Issuer)
Kersten Dirk (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/11/2024
3:36 PM
Dyne Therapeutics (Subject)
Farwell Wildon (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/11/2024
3:26 PM
Dyne Therapeutics (Subject)
McNeill Jonathan (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/11/2024
3:28 PM
Beskrovnaya Oxana (Reporting)
Dyne Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/11/2024
3:31 PM
Dyne Therapeutics (Subject)
Scalzo Richard William (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/11/2024
3:34 PM
Dyne Therapeutics (Subject)
HIGH SUSANNA GATTI (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/11/2024
3:13 PM
Dyne Therapeutics (Issuer)
HIGH SUSANNA GATTI (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/11/2024
3:13 PM
Dyne Therapeutics (Issuer)
Scalzo Richard William (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/11/2024
3:13 PM
Beskrovnaya Oxana (Reporting)
Dyne Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/10/2024
3:05 PM
Dyne Therapeutics (Issuer)
Scalzo Richard William (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/06/2024
3:22 PM
Dyne Therapeutics (Subject)
Scalzo Richard William (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/05/2024
3:34 PM
Dyne Therapeutics (Subject)
McNeill Jonathan (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/04/2024
4:42 PM
Cox John (Reporting)
Dyne Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/03/2024
5:14 PM
Dyne Therapeutics (Issuer)
Kerr Douglas (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
09/03/2024
5:16 PM
Dyne Therapeutics (Issuer)
Friedl-Naderer Johanna (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/03/2024
5:20 PM
Dyne Therapeutics (Issuer)
Friedl-Naderer Johanna (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
09/03/2024
5:22 PM
Dyne Therapeutics (Issuer)
Kerr Douglas (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/03/2024
6:16 AM
Dyne Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/30/2024
3:05 PM
Dyne Therapeutics (Issuer)
Kersten Dirk (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/28/2024
3:05 PM
Dyne Therapeutics (Issuer)
Kersten Dirk (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/22/2024
3:05 PM
Dyne Therapeutics (Issuer)
Kersten Dirk (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/20/2024
3:26 PM
Beskrovnaya Oxana (Reporting)
Dyne Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/20/2024
3:26 PM
Dyne Therapeutics (Issuer)
HIGH SUSANNA GATTI (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/20/2024
3:27 PM
Dyne Therapeutics (Issuer)
Farwell Wildon (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/20/2024
3:27 PM
Dyne Therapeutics (Issuer)
McNeill Jonathan (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/20/2024
3:28 PM
Dyne Therapeutics (Issuer)
Scalzo Richard William (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/19/2024
3:13 PM
Dyne Therapeutics (Subject)
Farwell Wildon (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/19/2024
3:08 PM
Dyne Therapeutics (Subject)
HIGH SUSANNA GATTI (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/19/2024
3:10 PM
Dyne Therapeutics (Subject)
McNeill Jonathan (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/19/2024
3:11 PM
Beskrovnaya Oxana (Reporting)
Dyne Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/19/2024
3:12 PM
Dyne Therapeutics (Subject)
Scalzo Richard William (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/12/2024
4:15 PM
Dyne Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/12/2024
4:05 PM
Dyne Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/08/2024
3:37 PM
Dyne Therapeutics (Subject)
Forbion Capital Fund IV Cooperatief U.A. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/03/2024
8:00 PM
Dyne Therapeutics (Issuer)
HIGH SUSANNA GATTI (Reporting)
Form 4/A
06/24/2024
7:41 PM
Dyne Therapeutics (Issuer)
HIGH SUSANNA GATTI (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/13/2024
8:45 PM
Dyne Therapeutics (Issuer)
HIGH SUSANNA GATTI (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/11/2024
6:41 PM
Dyne Therapeutics (Issuer)
Farwell Wildon (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/11/2024
6:42 PM
Beskrovnaya Oxana (Reporting)
Dyne Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/11/2024
6:28 PM
Dyne Therapeutics (Issuer)
Scalzo Richard William (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/11/2024
6:34 PM
Dyne Therapeutics (Issuer)
McNeill Jonathan (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/11/2024
6:34 PM
Dyne Therapeutics (Issuer)
HIGH SUSANNA GATTI (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/11/2024
3:32 PM
Dyne Therapeutics (Subject)
Farwell Wildon (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/10/2024
3:33 PM
Dyne Therapeutics (Subject)
HIGH SUSANNA GATTI (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/10/2024
3:36 PM
Dyne Therapeutics (Subject)
Scalzo Richard William (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/24/2024
4:10 PM
Dyne Therapeutics (Issuer)
Lubner David Charles (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
Trump’s Great Society (Ad)

Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to move your money now.

Millions of Americans are about to be wiped out, while others could make a fortune… click here to ma
05/24/2024
4:10 PM
Dyne Therapeutics (Issuer)
Rhodes Jason P (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/24/2024
4:10 PM
Dyne Therapeutics (Issuer)
HURWITZ EDWARD (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/24/2024
4:10 PM
Dyne Therapeutics (Issuer)
Kersten Dirk (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/24/2024
4:10 PM
Dyne Therapeutics (Issuer)
Incerti Carlo (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/24/2024
4:10 PM
Dyne Therapeutics (Issuer)
Stehman-Breen Catherine (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/22/2024
8:01 PM
Beskrovnaya Oxana (Reporting)
Dyne Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/22/2024
3:30 PM
Dyne Therapeutics (Filer)
Form 424B5
05/22/2024
6:59 AM
Dyne Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/20/2024
5:00 PM
Beskrovnaya Oxana (Reporting)
Dyne Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
(Data available from 1/1/2016 forward)

Remove Ads

Related Companies and Tools


This page (NASDAQ:DYN) was last updated on 3/29/2025 by MarketBeat.com Staff
From Our Partners